Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology
Xinpeng Shen(University of Minnesota), Matthew L. Senjem(Mayo Clinic in Florida), Danielle Harvey(UC San Diego Health System), Nick C. Fox(NIHR Queen Square Dementia Biomedical Research Unit), Gus Jiminez(UC San Diego Health System), John Q. Trojanowki(University of Southern California), Iris Sim(University of California San Diego), Andrew J. Saykin(Alzheimer’s Disease Neuroimaging Initiative), Tamie Sather(University of California San Diego), María C. Carrillo(Brigham and Women's Hospital), Michael Donohue(Alzheimer’s Disease Neuroimaging Initiative), Tom Montine(University of Washington), Charles DeCarli(University of California Davis Medical Center), Ronald G. Thomas(UC San Diego Health System), Prashanthi Vemuri(Mayo Clinic in Arizona), Norbert Schuff(University of California, Davis), Sarah Walter(UC San Diego Health System), György Simon(University of Minnesota), Bret Borowski(Mayo Clinic in Florida), Franz Hefti(Washington University in St. Louis), Laurel Beckett(Brigham and Women's Hospital), Sisi Ma(MNGI Digestive Health), William J. Jagust(Lawrence Berkeley National Laboratory), John C. Morris(Washington University in St. Louis), Jennifer Mason(University of California San Diego), Greg Sorensen(Alzheimer's Association), Ronald Petersen(Mayo Clinic in Arizona), Peter J. Davies(Texas A&M Health Science Center), Matt A. Bernstein(University of London), Peter J. Snyder(University of Connecticut), Zaven S. Khachaturian(University of Southern California), David M. Holtzman(Hope Center for Neurological Disorders), Archana B. Balasubramanian(University of California San Diego), Paul M. Thompson(University of Southern California), Leslie M. Shaw(California University of Pennsylvania), Robert C. Green(Boston University), Howard Fillit(Alzheimer's Drug Discovery Foundation), Michael W. Weiner(University of California, San Francisco), M. Marcel Mesulam(Northwestern University), Adam J. Schwartz(Eli Lilly (United States)), Devon Gessert(UC San Diego Health System), Paul Aisen(University of Southern California), William C. Potter(Eli Lilly (United States)), Steven M. Paul(Baker Engineering (United States)), Marc Raichle(Washington University in St. Louis), Lew Kuller(Washington University in St. Louis), Clifford R. Jack(Mayo Clinic), Jeff Gunter(Mayo Clinic in Florida), Arthur W. Toga(University of California, Los Angeles)
Cited by 135
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k